Literature DB >> 10408275

13C cross-polarization magic angle spinning NMR and gauge-independent atomic orbital, coupled Hartree-Fock calculations of buspirone analogues. Part 2. Hydrochlorides and perchlorates of 1-arylpiperazine-4-alkylimides.

A Szelejewska-Woźniakowska1, Z Chilmonczyk, A Leś, J Cybulski, I Wawer.   

Abstract

13C cross-polarization (CP) magic angle spinning (MAS) solid state NMR spectra of hydrochlorides and perchlorates of buspirone analogues (2-5) were recorded. In the spectra for each compound, one set of signals appeared, in agreement with single crystal X-ray diffraction data indicating the presence of one molecule per crystal unit. The resonances of 2-5 hydrochlorides were assigned by comparison with the solution chemical shifts. For perchlorate 2b and diperchlorate 2c, the reasonable assignment of signals was made with the aid of the theoretical studies. Ab initio calculations of the carbon shieldings were performed by means of the GIAO-CHF method for two model systems: perchlorate and diperchlorate of quinoline-(N-methyl)piperazine. As no remarkable differences between carbon chemical shifts of hydrochlorides 3-5 in solid state and in solution were observed, it was concluded that in solution these compounds adopted the same conformation as in the solid state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408275     DOI: 10.1016/s0926-2040(99)00010-7

Source DB:  PubMed          Journal:  Solid State Nucl Magn Reson        ISSN: 0926-2040            Impact factor:   2.293


  2 in total

1.  Correlation between the pKa and nuclear shielding of α-hydrogen of ketones.

Authors:  Suting Xing; Juanfeng Lu; Xinyun Zhao; Xi Chen; Chang-Guo Zhan
Journal:  J Mol Model       Date:  2019-11-25       Impact factor: 1.810

2.  Correlations between the 1H NMR chemical shieldings and the pKa values of organic acids and amines.

Authors:  Juanfeng Lu; Tingting Lu; Xinyun Zhao; Xi Chen; Chang-Guo Zhan
Journal:  J Mol Model       Date:  2018-06-01       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.